CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-08-05 | FOEHR MATTHEW W President and COO | Exercise or conversion | +12,500 | $9.97 | $125K | 91,412 |
| 2016-08-05 | FOEHR MATTHEW W President and COO | Sale | −12,500 | $122.14 | $1.5M | 78,912 |
| 2016-08-05 | FOEHR MATTHEW W President and COO | Exercise or conversion · Employee Stock Option (right to buy) | −12,500 | 70,860 | ||
| 2016-08-05 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +4,295 | $21.92 | $94K | 33,942 |
| 2016-08-05 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −4,295 | $123.16 | $529K | 29,647 |
| 2016-08-05 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +5,688 | $56.26 | $320K | 35,335 |
| 2016-08-05 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −5,688 | $123.16 | $701K | 29,647 |
| 2016-08-05 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +12,084 | $74.42 | $899K | 41,731 |
| 2016-08-05 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −12,084 | $123.16 | $1.5M | 29,647 |
| 2016-08-05 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +4,947 | $42.90 | $212K | 34,594 |
| 2016-08-05 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +3,333 | $40.86 | $136K | 37,927 |
| 2016-08-05 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Employee Stock Option (right to buy) | −3,333 | 0 | ||
| 2016-08-05 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Employee Stock Option (right to buy) | −4,947 | 0 | ||
| 2016-08-05 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Employee Stock Option (right to buy) | −5,688 | 10,369 | ||
| 2016-08-05 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Employee Stock Option (right to buy) | −12,084 | 7,916 | ||
| 2016-08-05 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,295 | 469 | ||
| 2016-08-01 | KOZARICH JOHN W Director | Sale | −200 | $135.78 | $27K | 41,783 |
| 2016-08-01 | KOZARICH JOHN W Director | Sale | −500 | $137.60 | $69K | 41,283 |
| 2016-08-01 | KOZARICH JOHN W Director | Sale | −200 | $138.31 | $28K | 41,083 |
| 2016-08-01 | KOZARICH JOHN W Director | Sale | −100 | $139.51 | $14K | 40,983 |
Page 61 of 86 · 1,712 trades